Understanding Tirzepatide: A Game Changer in Diabetes and Obesity Treatment
Tirzepatide is revolutionizing the treatment landscape for type 2 diabetes and obesity. As a novel, once-weekly dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, tirzepatide has shown remarkable efficacy in managing these complex metabolic disorders. This article delves into its mechanisms of action, key research findings from 2025, and its potential […]